Marantz Jing L.
Reporting owner on Forms 3, 4 and 5, CIK 1834528.
Marantz Jing L. reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-10-28.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| NTLA · Intellia Therapeutics, Inc.CIK 1652130 | officer (EVP, Chief Medical Officer) | 1 | 2026-10-28 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| NTLA · Intellia Therapeutics, Inc.Common Stock | 2026-10-26 | A granted | +199,822 | $0 | 199,822 | Form 4 |
| NTLA · Intellia Therapeutics, Inc.Stock Option (right to buy), derivative | 2026-10-26 | A granted | +275,061 | $0 | 275,061 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-436131 | Intellia Therapeutics, Inc. | 2026-10-28 | ||
| Form 3 0001193125-26-436123 | Intellia Therapeutics, Inc. | 2026-10-28 |